These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15635971)

  • 1. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults.
    Vyse AJ; Gay NJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Infect; 2004 Dec; 132(6):1129-34. PubMed ID: 15635971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Dec; 132(6):1121-7. PubMed ID: 15635970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy.
    Kudesia G; Partridge S; Farrington CP; Soltanpoor N
    J Clin Pathol; 2002 Feb; 55(2):154-5. PubMed ID: 11865016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of varicella-zoster virus in Bangladesh.
    Saha SK; Darmstadt GL; Hanif M; Khan R
    Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of varicella-zoster virus in the German population.
    Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
    Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The seroepidemiology of the varicella-zoster virus in children and adolescents].
    Gil Miguel A; Lasheras Lozano ML; Jiménez García R; Calle Purón ME; Santos Santos M; Rey Calero J; Martín Hernández D
    Aten Primaria; 1993 May; 11(8):416-8. PubMed ID: 8388262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data.
    Aebi C; Fischer K; Gorgievski M; Matter L; Mühlemann K
    Vaccine; 2001 Apr; 19(23-24):3097-103. PubMed ID: 11312004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella susceptibility and transmission dynamics in Slovenia.
    Socan M; Berginc N; Lajovic J
    BMC Public Health; 2010 Jun; 10():360. PubMed ID: 20573202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka.
    Liyanage NP; Fernando S; Malavige GN; Mallikahewa R; Sivayogan S; Jiffry MT; Vitarana T
    Indian J Med Sci; 2007 Mar; 61(3):128-34. PubMed ID: 17337813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.
    Koskiniemi M; Lappalainen M; Schmid DS; Rubtcova E; Loparev VN
    Clin Vaccine Immunol; 2007 Sep; 14(9):1057-61. PubMed ID: 17626161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.